CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Parkinson’s cell therapy developer files to go public

IPO/OfferingPositive
AI Analysis

Summary

Aspen Neuroscience, a Parkinson's cell therapy developer, filed to go public on Nasdaq to raise capital for its lead program that converts patient cells into dopamine-producing neurons.

Importance:6/10
Sentiment:
0.50
IPOcell therapyParkinson'sdopamine neurons

Read the original article

Published by BioPharma Dive on October 12, 2026 3:58 PM

Read Original